BBA
ALXN
Baker Bros. Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-3,993,312
| Closed | -$611M | – | 134 |
|
|
2021
Q1 | $611M | Sell |
3,993,312
-4,767,482
| -54% | -$729M | 2.65% | 6 |
|
|
2020
Q4 | $1.37B | Hold |
8,760,794
| – | – | 5.16% | 6 |
|
|
2020
Q3 | $1B | Hold |
8,760,794
| – | – | 4.01% | 5 |
|
|
2020
Q2 | $983M | Hold |
8,760,794
| – | – | 4.34% | 5 |
|
|
2020
Q1 | $787M | Buy |
8,760,794
+502,726
| +6% | +$45.1M | 4.84% | 5 |
|
|
2019
Q4 | $893M | Hold |
8,258,068
| – | – | 4.75% | 5 |
|
|
2019
Q3 | $809M | Hold |
8,258,068
| – | – | 5.5% | 5 |
|
|
2019
Q2 | $1.08B | Sell |
8,258,068
-300,000
| -4% | -$39.3M | 7.35% | 4 |
|
|
2019
Q1 | $1.16B | Buy |
8,558,068
+2,174
| +0% | +$294K | 7.41% | 4 |
|
|
2018
Q4 | $833M | Hold |
8,555,894
| – | – | 6.82% | 4 |
|
|
2018
Q3 | $1.19B | Hold |
8,555,894
| – | – | 7.83% | 4 |
|
|
2018
Q2 | $1.06B | Hold |
8,555,894
| – | – | 7.98% | 4 |
|
|
2018
Q1 | $954M | Buy |
8,555,894
+2,030
| +0% | +$226K | 8.08% | 4 |
|
|
2017
Q4 | $1.02B | Hold |
8,553,864
| – | – | 8.87% | 3 |
|
|
2017
Q3 | $1.2B | Hold |
8,553,864
| – | – | 9.73% | 3 |
|
|
2017
Q2 | $1.04B | Buy |
8,553,864
+2,009,734
| +31% | +$245M | 9.1% | 3 |
|
|
2017
Q1 | $793M | Buy |
6,544,130
+835
| +0% | +$101K | 6.49% | 4 |
|
|
2016
Q4 | $801M | Hold |
6,543,295
| – | – | 7.85% | 3 |
|
|
2016
Q3 | $802M | Hold |
6,543,295
| – | – | 7.28% | 5 |
|
|
2016
Q2 | $764M | Buy |
6,543,295
+696
| +0% | +$81.3K | 8.01% | 5 |
|
|
2016
Q1 | $911M | Hold |
6,542,599
| – | – | 9.61% | 3 |
|
|
2015
Q4 | $1.25B | Hold |
6,542,599
| – | – | 10.34% | 3 |
|
|
2015
Q3 | $1.02B | Hold |
6,542,599
| – | – | 9.45% | 3 |
|
|
2015
Q2 | $1.18B | Buy |
+6,542,599
| New | +$1.18B | 10.37% | 3 |
|